Face to Face or Digitally Delivered First-line Osteoarthritis Treatment?
NCT ID: NCT04836988
Last Updated: 2023-10-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
6946 participants
OBSERVATIONAL
2021-03-06
2021-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Osteoarthritis Outcomes in Different Ages
NCT05208463
Minimal Clinically Important Changes in Osteoarthritis Treatment
NCT05316194
Effects of 12-week Digital Treatment in Patients With Hand OA on Pain and Function
NCT05499559
PT-led Triage for Patients With Hip o Knee Osteoarthritis
NCT04665908
Exercise Therapy in Patients With Knee Osteoarthritis
NCT02024126
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Statistical analysis In this study we will include all participants in the digital program fulfilling the eligibility criteria outlined below (n \>2000). These participants will be matched 1:1 to participants in the BOA register using the propensity scoring approach. The minimum clinically important difference is typically considered to be one unit on a 0-10 NRS scale. To obtain a 95% confidence interval for the between-group difference with a width of at most 0.5 units (i.e. very precise) in a sample with a typical standard deviation of 1.5, with 99% probability, we will need \~630 patients in total.
We will use observational data to emulate an equivalence trial comparing the effect on joint pain of a digitally delivered first-line intervention and of an in-person delivered first line intervention for people with OA of the hip or knee. In order to establish equivalence between the interventions the pain change after the intervention should differ of less than 1-point on a 0-10 NRS pain scale. This cut off was selected based on previous work identifying 1-point change as the MCID in people with OA. The main outcome will be analyzed using a propensity score matching approach. We will estimate the propensity score using a logistic regression model, in which we will regress the treatment status on the observed baseline characteristics of the participants. The characteristics to include in the propensity score will be selected using the disjunctive cause criteria, including factors in the analysis identified as causes of treatment allocation(exposure) and/or the pain change (outcome). We will use nearest neighbor matching to select controls (BOA participants) whose propensity score is closest to that of the treated subject. Furthermore, we will use an optimal matching strategy to minimize the total within-pair difference of the propensity score. Within-pair differences in main outcome will be analysed using a paired t-test. Finally, we will adjust the analysis for baseline pain in order to increase the precision of the estimates and minimize the regression to the mean effect
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Digitally delivered osteoarthritis treatment
Participants enrolled in the digitally delivered osteoarthritis managament program (Joint Academy register)
Three months of digitally delivered osteoarthritis treatment
Digitally delivered osteoarthritis management including education and exercise and weight control if needed
Face-to-face delivered osteoarthritis treatment
Participants enrolled in the face-to-face delivered osteoarthritis managament program (BOA-register)
Three months of face-to-face delivered osteoarthritis treatment
Face-toface delivered osteoarthritis management including education and exercise and weight control if needed
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Three months of digitally delivered osteoarthritis treatment
Digitally delivered osteoarthritis management including education and exercise and weight control if needed
Three months of face-to-face delivered osteoarthritis treatment
Face-toface delivered osteoarthritis management including education and exercise and weight control if needed
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participated for three months in any of the programs between 2018-04-01 and 2020- 03-31
* Reported pain at both baseline and at 3 months follow-up
* Adherence of ≥80%, i.e., ≥80% completed education videos, exercises and questionnaires offered in the digital program and participation in two out of three educational lessons and at least 10 of the 12 supervised group exercise sessions offered in the BOA.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lund University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anna Cronström
Role: PRINCIPAL_INVESTIGATOR
Lund University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lund University
Lund, Skåne County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Observational
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.